PRICE T ROWE ASSOCIATES INC /MD/ - FIBROGEN INC ownership

FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 168 filers reported holding FIBROGEN INC in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of FIBROGEN INC
ValueSharesWeighting
Q3 2023$62
-50.8%
70,704
+52.7%
0.00%
Q2 2023$126
-99.2%
46,304
-94.3%
0.00%
-100.0%
Q1 2023$15,090
+1.5%
808,623
-12.9%
0.00%0.0%
Q4 2022$14,869
-96.6%
928,134
+2689.2%
0.00%
Q3 2022$433,000
+101.4%
33,276
+63.4%
0.00%
Q2 2022$215,000
+2.9%
20,362
+16.9%
0.00%
Q1 2022$209,000
+12.4%
17,423
+31.8%
0.00%
Q4 2021$186,000
-42.4%
13,219
-58.2%
0.00%
Q3 2021$323,000
-97.6%
31,614
-93.6%
0.00%
-100.0%
Q2 2021$13,221,000
-79.9%
496,486
-73.8%
0.00%
-85.7%
Q1 2021$65,882,000
-51.0%
1,898,067
-47.7%
0.01%
-50.0%
Q4 2020$134,540,000
-15.0%
3,627,397
-5.8%
0.01%
-22.2%
Q3 2020$158,347,000
-5.1%
3,850,863
-6.5%
0.02%
-14.3%
Q2 2020$166,867,000
+134.0%
4,117,117
+100.6%
0.02%
+90.9%
Q1 2020$71,306,000
-28.9%
2,051,977
-12.3%
0.01%
-15.4%
Q4 2019$100,319,000
+9.1%
2,338,980
-5.9%
0.01%0.0%
Q3 2019$91,922,000
-17.9%
2,485,729
+0.3%
0.01%
-18.8%
Q2 2019$112,001,000
-19.1%
2,478,994
-2.7%
0.02%
-20.0%
Q1 2019$138,446,000
+31.4%
2,547,311
+11.9%
0.02%
+11.1%
Q4 2018$105,394,000
-25.9%
2,277,308
-2.8%
0.02%
-14.3%
Q3 2018$142,281,000
-3.7%
2,342,077
-0.8%
0.02%
-8.7%
Q2 2018$147,807,000
+64.1%
2,361,134
+21.1%
0.02%
+64.3%
Q1 2018$90,097,000
+18.0%
1,950,141
+21.0%
0.01%
+16.7%
Q4 2017$76,367,000
+4.9%
1,611,127
+19.1%
0.01%0.0%
Q3 2017$72,791,000
+179.8%
1,352,993
+68.0%
0.01%
+140.0%
Q2 2017$26,016,000
+30.1%
805,453
-0.7%
0.01%
+25.0%
Q1 2017$19,991,000
+9.7%
811,013
-4.8%
0.00%0.0%
Q4 2016$18,228,000
-2.6%
851,799
-5.8%
0.00%0.0%
Q3 2016$18,711,000
+23.2%
903,929
-2.4%
0.00%
+33.3%
Q2 2016$15,191,000
-23.0%
925,727
-0.1%
0.00%
-25.0%
Q1 2016$19,722,000
-30.3%
926,327
-0.3%
0.00%
-33.3%
Q4 2015$28,309,000
+39.8%
929,067
+0.6%
0.01%
+20.0%
Q3 2015$20,251,000
-7.7%
923,837
-1.1%
0.01%0.0%
Q2 2015$21,950,000
-27.5%
934,036
-4.4%
0.01%
-16.7%
Q1 2015$30,258,000
+14.6%
977,436
-0.1%
0.01%0.0%
Q4 2014$26,398,000978,7360.01%
Other shareholders
FIBROGEN INC shareholders Q4 2021
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 305,784$8,143,0008.63%
Vantage Consulting Group Inc 605,713$16,130,0002.81%
GREAT POINT PARTNERS LLC 500,000$13,315,0002.79%
HHLR ADVISORS, LTD. 3,955,787$105,343,0001.08%
Intercontinental Wealth Advisors, LLC 191,300$5,094,0001.01%
Ikarian Capital, LLC 250,000$6,657,0000.54%
BHK Investment Advisors, LLC 45,100$1,201,0000.49%
Ikarian Capital, LLC 193,800$5,161,0000.42%
Omega Fund Management, LLC 130,646$3,479,0000.39%
Rhenman & Partners Asset Management AB 200,000$5,326,0000.36%
View complete list of FIBROGEN INC shareholders